0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector [Cyltezo]
RxNorm concept 2640898, branded drug (sbd). Prescribable name: CYLTEZO 40 MG in 0.8 ML Auto-Injector.
- RxCUI
- 2640898
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2640898 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
0.8 ML Cyltezo 50 MG/ML Auto-Injector; Cyltezo 40 MG per 0.8 ML Auto-Injector
Related concepts
- adalimumab-adbm 50 MG/ML (SCDC, consists of)
- adalimumab-adbm 50 MG/ML [Cyltezo] (SBDC, consists of)
- {4 (0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector [Cyltezo]) } Pack [Cyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis] (BPCK, contained in)
- {6 (0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector [Cyltezo]) } Pack [Cyltezo Pen 40 MG/0.8 ML Starter Package for Crohn's Disease or Ulcerative Colitis] (BPCK, contained in)
- Auto-Injector (DF, has dose form)
- Cyltezo (BN, has ingredient)
- 0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2640898 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2640898 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2640898. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.